|
Sign In to gain access to subscriptions and/or personal tools.
|
Effects of telmisartan, hydrochlorothiazide and their combination on blood pressure and renal excretory parameters in spontaneously hypertensive rats
Wolfgang Wienen
Department of Pharmacological Research, Boehringer Ingelheim, Biberach an der Riss, Germany, wolfgang. wienen{at}bc.boehringer-ingelheim.com
Hans-Joachim Schierok
Department of Pharmacological Research, Boehringer Ingelheim, Biberach an der Riss, Germany
The effects of telmisartan and hydrochlorothiazide (HCTZ) alone and in combination on blood pressure (BP) and renal excretory function were investigated in male spontaneously hypertensive rats (SHR) after oral administration for five consecutive days. Four treatments were studied: vehicle (0.5% NatrosolTM), telmisartan 3 mg/kg, HCTZ 10 mg/kg, and telmisartan 3 mg/kg+ HCTZ 10 mg/kg. The effects on BP and heart rate were studied in 40 SHRs (10 animals per group) using an implanted telemetry device. Renal excretory function was assessed in 76 SHRs (18 animals per group, of which nine were used for urine sampling and nine for blood sampling).
The telmisartan/HCTZ combination produced the greatest reductions in trough DBP (—44±1.5 mmHg), SBP (—60±1.9 mmHg) and mean BP (mBP; —53±1.7 mmHg) after five days of therapy (p<0.05 vs. vehicle and vs. telmisartan). Telmisartan monotherapy also decreased DBP, SBP and mBP significantly (p<0.05), but only minor BP fluctuations occurred in SHRs receiving HCTZ or vehicle. Telmisartan/HCTZ elevated heart rate by approximately 12 beats per minute (p<0.05 vs. control). Significant increases in urine volume and Na+, Cl—, K+, creatinine and glucose excretion were observed with HCTZ treatment (p<0.01). Telmisartan/HCTZ also promoted renal water and electrolyte excretion (p<0.01); the diuretic effect appeared to be greater with the combination than with HCTZ alone, and there was some attenuation of urinary K+ loss. Elevated blood urea nitrogen levels were observed only in HCTZ-treated SHRs. These results indicate that the antihypertensive efficacy of telmisartan in SHRs is augmented by co-administration with HCTZ. The combination did not affect renal excretory function, with the exception of an increase in blood urea nitrogen and a possible amelioration of HCTZ-related K+ depletion.
Key Words: telmisartan • spontaneously hypertensive rat • renal function • blood pressure • AT1-receptor antagonist • potassium • hypertension
References
- Andrén L., Weiner L., Svensson A., Hansson L. Enalapril with either a 'very low' or 'low' dose of hydrochlorothiazide is equally effective in essential hypertension.A double-blind trial in 100 hypertensive patients. J Hypertens 1983;1(Suppl 2):384-6.
- Morgan DB, Davidson C. Hypokalaemia and diuretics: an analysis of publications. BMJ 1980;280(6218):905-8.[Abstract/Free Full Text]
- Skoularigis J., Strugo V., Chopamba A., Setekge S., Sareli P. Low dose hydrochlorothiazide (12.5 to 25 mg daily) as monotherapy in black patients with mild to moderate hypertension. Assessment by ambulatory blood pressure monitoring. Am J Hypertens 1995;8(10 Pt 1):1046-50.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Weinberger MH Angiotensin converting enzyme inhibitors enhance the antihypertensive efficacy of diuretics and blunt or prevent adverse metabolic effects. J Cardiovasc Pharmacol 1989;13(Suppl 3):S1-4.
- Kochar M., Guthrie R.,Triscari J., Kassler-Taub K., Reeves RA Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension. Am J Hypertens 1999;12(8 Pt 1):797-805.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- McGill J., Reilly P. Identifying effective dose combinations of an A II antagonist and a diuretic in patients with hypertension (abstract). J Hum Hypertens 1999;13(Suppl 3):S10.
- Neutel JM, Smith DHG. Dose response and antihypertensive efficacy of the AT1-receptor antagonist telmisartan in patients with mild to moderate hypertension. Adv Ther 1998;15(4):206-17.[Web of Science]
- Wienen W.,Hauel N., van Meel JC,Narr B., Ries U., Entzeroth M. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277. Br J Pharmacol 1993;110(1):245-52.[Web of Science][Medline]
[Order article via Infotrieve]
- Wienen W., Entzeroth M. Effects on binding characteristics and renal function of the novel, non-peptide angiotensin II antagonist BIBR 277 in the rat. J Hypertens 1994;12(2):119-28.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Schierok H., Pairet M., Hauel N.,Wienen W. Effects of telmisartan, a new angiotensin AT1-receptor antagonist on renal excretory function in conscious dogs (abstract). Presented at the 1st International Symposium on Angiotensin II Antagonism, London, 28 September-1st October 1997.
- van Meel JCA, Hauel N., Entzeroth M., Haigh R., Wienen W. Antihypertensive effects of the angiotensin receptor antagonist, BIBR 277, in conscious renal hypertensive and spontaneously hypertensive rats (abstract). Br J Pharmacol 1993; 108(Suppl):191P.
- Bunkenburg B., Schnell C., Baum HP, Cumin F., Wood JM Prolonged angiotensin II antagonism in spontaneously hypertensive rats. Hemodynamic and biochemical consequences. Hypertension 1991;18(3):278-88.[Abstract/Free Full Text]
- Wong PC, Price WAJ, Chiu AT et al. Hypotensive action of DuP 753, an angiotensin II antagonist, in spontaneously hypertensive rats. Nonpeptide angiotensin II receptor antagonists: X. Hypertension 1990;15(5):459-68.[Abstract/Free Full Text]
- Böhm M., Lippoldt A., Wienen W., Ganten D., Bader M. Reduction of cardiac hypertrophy in TGR(mREN2)27 by angiotensin II receptor blockade. Mol Cell Biochem 1996; 163/164:217-21.
- Böhm M., Lee M., Kreutz R. et al. Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions. Hypertension 1995;13(8):891-9.[CrossRef]
- Wagner J., Drab M., Bohlender J., Amann K., Wienen W., Ganten D. Effects of AT1 receptor blockade on blood pressure and the renin-angiotensin system in spontaneously hypertensive rats of the stroke prone strain. Clin Exp Hypertens 1998;20(2):205-21.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Chillon JM, Capdeville-Atkinson C., Lartaud I., Guillou J., Mertes PM, Atkinson J. Chronic antihypertensive treatment with captopril plus hydrochlorothiazide improves aortic distensibility in the spontaneously hypertensive rat. Br J Pharmacol 1992;107(3):710-4.[Web of Science][Medline]
[Order article via Infotrieve]
- Wada T., Sanada T., Ojima M., Kanagawa R., Nishikawa K., Inada Y. Combined effects of the angiotensin II antagonist candesartan cilexetil (TCV-116) and other classes of antihypertensive drugs in spontaneously hypertensive rats. Hypertens Res 1996;19(4):247-54.[Medline]
[Order article via Infotrieve]
- Lai FM, Tanikella T., Herzlinger H., Goldstein B., Chan PS, Cervoni P. Studies on the mechanism of the enhancement of the antihypertensive activity of captopril by a diuretic in spontaneously hypertensive rats. Clin Exp Hypertens 1982;4(6): 1001-18.[CrossRef][Web of Science]
- MacKay JH,Arcuri KE, Goldberg AI, Snapinn SM, Sweet CS Losartan and low-dose hydrochlorothiazide in patients with essential hypertension.A double-blind, placebo-controlled trial of concomitant administration compared with individual components. Arch Intern Med 1996;156(3):278-85.[Abstract/Free Full Text]
- Benz JR, Black HR, Graff A., Reed A., Fitzsimmons S., Shi Y. Valsartan and hydrochlorothiazide in patients with essential hypertension.A multiple dose, double-blind, placebo controlled trial comparing combination therapy with monotherapy. J Hum Hypertens 1998;12(12):861-6.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Elliott WJ, for the Eprosartan Study Group. Double-blind comparison of eprosartan and enalapril on cough and blood pressure in unselected hypertensive patients. J Hum Hypertens 1999;13(6):413-7.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Oparil S. Candesartan cilexetil in combination with low-dose hydrochlorothiazide is effective in severe hypertension. Am J Cardiol 1999;84(Suppl 10A):35S-41S.[CrossRef][Web of Science][Medline]
[Order article via Infotrieve]
- Kushida H., Nomura S., Morita O. et al. Pharmacological characterization of the nonpeptide angiotensin II receptor antagonist, U-97018. J Pharmacol Exp Ther 1995;274(3):1042-53.[Abstract/Free Full Text]
- Wood JM, Mah SC, Schnell C. Comparison of the acute hypotensive effects of renin inhibition, converting enzyme inhibition, and angiotensin II antagonism in rats. J Cardiovasc Pharmacol 1990;16(Suppl 4):S60-4.[Web of Science][Medline]
[Order article via Infotrieve]
- Weinberger MH Diuretics and their side effects. Dilemma in the treatment of hypertension. Hypertension 1988;11(Suppl II)(3):1116-20.
Journal of Renin-Angiotensin-Aldosterone System, Vol. 2, No. 2,
123-128 (2001)
DOI: 10.3317/jraas.2001.013
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
X. Zhou, L. C. Matavelli, H. Ono, and E. D. Frohlich
Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR
Am J Physiol Renal Physiol,
October 1, 2005;
289(4):
F871 - F879.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
